We are live on
!
Find out more
FA
FCG Advisors Portfolio holdings
AUM
$425M
1-Year Est. Return
12.09%
This Fund
S&P 500
This Quarter
Est. Return
-6.44%
1 Year Est. Return
+12.09%
3 Year Est. Return
+19.73%
5 Year Est. Return
+52.93%
10 Year Est. Return
–
AUM
$121M
AUM Growth
-$6.13M
(-4.8%)
Cap. Flow
+$23.5M
Cap. Flow
% of AUM
19.43%
Top 10 Holdings %
Top 10 Hldgs %
56.35%
Holding
85
New
6
Increased
53
Reduced
16
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$17M |
| 2 |
Vanguard Extended Market ETF
VXF
|
+$1.23M |
| 3 |
iShares S&P 500 Growth ETF
IVW
|
+$792K |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$636K |
| 5 |
Apple
AAPL
|
+$486K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$443K |
| 2 |
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
|
+$272K |
| 3 |
SLB Ltd
SLB
|
+$252K |
| 4 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$228K |
| 5 |
Novartis
NVS
|
+$211K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.03% |
| 2 | Financials | 5.07% |
| 3 | Technology | 3.72% |
| 4 | Communication Services | 2.35% |
| 5 | Energy | 1.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Intel
INTC
$478B
| $181K | 0.15% |
+10,660
| New | +$308K |
|
|
YTEN
77
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
| $115K | 0.09% |
12
+3
| +33% | +$77K |
|
|
TLRA
78
DELISTED
Telaria, Inc.
TLRA
| $46K | 0.04% |
+24,784
| New | +$56.4K |
|
|
ONCT
79
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $18K | 0.01% |
17
| – | – |
|
|
UQM
80
DELISTED
UQM Technologies, Inc.
UQM
| $6K | 0.01% |
10,000
| – | – |
|
|
81
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.33B
| – | – |
-10,468
| Closed | -$272K |
|
|
82
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.36B
| – | – |
-3,841
| Closed | -$443K |
|
|
83
Novartis
NVS
$293B
| – | – |
-2,390
| Closed | -$211K |
|
|
84
SLB Ltd
SLB
$70.3B
| – | – |
-2,927
| Closed | -$252K |
|
|
RDS.A
85
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| – | – |
-4,003
| Closed | -$228K |
|
Similar funds
LWS
VCP
CCM
AIM
MGAI
CPF
IA
F
FCG Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, FCG Advisors held 85 positions worth $121M, down 4.8% from $127M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
FCG Advisors deployed $23.5M of net new capital in Q3 2015, opening 6 new positions and adding to 53 existing holdings. Its largest new stake was Vanguard Dividend Appreciation ETF: 4,747 shares worth $350K.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 25% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Vanguard Short-Term Corporate Bond ETF, an estimated $200K trimmed.
- FCG Advisors's largest Q3 2015 buy was Vanguard Dividend Appreciation ETF: 4,747 shares worth $350K.
- FCG Advisors added most to Celgene Corp in Q3 2015, an estimated $17M increase.
- FCG Advisors's biggest Q3 2015 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $200K.
- FCG Advisors fully exited State Street SPDR Bloomberg High Yield Bond ETF in Q3 2015, selling an estimated $443K.
- FCG Advisors's ten largest holdings make up 56% of its $121M portfolio in Q3 2015.
- FCG Advisors opened 6 new positions and closed 5 in Q3 2015.
- FCG Advisors's portfolio value fell 4.8% quarter-over-quarter to $121M.
Based on FCG Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.